Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-68,688
Closed -$7.6M 133
2026
Q1
$7.6M Sell
68,688
-27,144
-28% -$3.71M 0.4% 50
2025
Q4
$17.5M Buy
95,832
+40,807
+74% +$7.27M 0.88% 30
2025
Q3
$9.63M Sell
55,025
-9,562
-15% -$1.6M 0.66% 36
2025
Q2
$9.39M Buy
64,587
+53,747
+496% +$7.62M 0.86% 34
2025
Q1
$1.9M Sell
10,840
-8,412
-44% -$1.63M 0.19% 46
2024
Q4
$4.04M Buy
19,252
+5,584
+41% +$1.3M 0.36% 46
2024
Q3
$3.93M Buy
13,668
+1,026
+8% +$324K 0.27% 44
2024
Q2
$3.96M Sell
12,642
-2,705
-18% -$848K 0.27% 52
2024
Q1
$5.16M Sell
15,347
-70
-0.5% -$20.6K 0.34% 49
2023
Q4
$4.36M Sell
15,417
-5,581
-27% -$1.44M 0.38% 41
2023
Q3
$5.17M Sell
20,998
-50,728
-71% -$12.8M 0.44% 41
2023
Q2
$17.9M Sell
71,726
-5,062
-7% -$1.07M 1.5% 17
2023
Q1
$16.4M Buy
76,788
+10,095
+15% +$2.25M 1.14% 19
2022
Q4
$13M Buy
66,693
+56,481
+553% +$11.2M 1.13% 19
2022
Q3
$1.88M Buy
10,212
+4,625
+83% +$1.01M 0.16% 50
2022
Q2
$1.21M Sell
5,587
-41,229
-88% -$9.25M 0.09% 63
2022
Q1
$11.4M Sell
46,816
-5,051
-10% -$1.27M 0.87% 32
2021
Q4
$16.1M Sell
51,867
-20,044
-28% -$5.61M 1.03% 27
2021
Q3
$18.8M Buy
+71,911
New +$17.5M 1.3% 21

Other funds holding ICLR

Eversept Partners's ICLR Position: Q2 2026 in Review

Eversept Partners sold out of Icon (ICLR) in Q2 2026, closing a stake of 68,688 shares — an estimated $7.6M sold.

Eversept Partners first reported a position in ICLR in Q3 2021 and held it in 19 quarters. The position peaked at $18.8M in Q3 2021. 422 funds tracked by Wall St. Rank hold ICLR as of Q2 2026.

  • Eversept Partners reported no remaining Icon position as of Q2 2026 after selling out during the quarter.
  • Eversept Partners sold 68,688 Icon shares in Q2 2026, an estimated $7.6M.
  • Eversept Partners first reported a position in Icon in Q3 2021 and held it in 19 quarters.
  • Eversept Partners's Icon position peaked at $18.8M in Q3 2021.
  • 422 funds tracked by Wall St. Rank held Icon as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.